Comparative epidemiology of chronic fatigue syndrome in Brazilian and British primary care: prevalence and recognition.
Cho, Hyong Jin, Menezes, Paulo Rossi, Hotopf, Matthew et al. · The British journal of psychiatry : the journal of mental science · 2009 · DOI
Quick Summary
This study looked at how often ME/CFS occurs in two very different cities—London and São Paulo, Brazil—and whether doctors recognize it as a real condition. Researchers surveyed over 6,000 primary care patients and found that ME/CFS affected roughly the same number of people in both places (about 2%). However, while British doctors had diagnosed some cases, Brazilian doctors had not diagnosed any, suggesting that cultural and healthcare system differences affect how the disease is recognized rather than how common it actually is.
Why It Matters
This study provides important evidence that ME/CFS is a genuine global health condition affecting similar proportions of populations across diverse cultures and economic contexts. It highlights how healthcare systems and cultural attitudes significantly impact whether patients receive a diagnosis, which has implications for understanding patient experiences worldwide and advocating for better recognition of the disease in underserving healthcare systems.
Observed Findings
ME/CFS prevalence by CDC 1994 criteria was 2.1% in London and 1.6% in São Paulo (not statistically significantly different).
Formal physician diagnoses of ME/CFS were documented in 11 British patients but zero Brazilian patients.
The difference in diagnosis rates between countries was highly statistically significant (p<0.001) despite comparable prevalence estimates.
Medical record review was the source for identifying formal diagnoses, revealing a gap between symptom prevalence and clinical recognition.
Inferred Conclusions
ME/CFS occurs at similar rates across culturally and economically distinct populations, suggesting it is not primarily a disease of wealthy Western nations.
Physician recognition and labeling of ME/CFS as a discrete diagnostic entity is substantially influenced by cultural and healthcare system factors rather than actual disease prevalence.
Cultural attitudes and clinical training regarding ME/CFS may create significant barriers to diagnosis in some healthcare systems despite comparable symptom burden.
Remaining Questions
What specific cultural, educational, or healthcare system factors in Brazil account for the complete absence of formal diagnoses despite comparable symptom prevalence?
How do diagnostic recognition patterns differ in other countries, and are there common factors predicting which healthcare systems recognize ME/CFS?
What This Study Does Not Prove
This study does not prove that ME/CFS is identically caused or experienced across all cultures, nor does it explain the specific mechanisms behind differential recognition. It cannot establish whether differences in diagnosis reflect true diagnostic bias, different patient presentation patterns, or healthcare access barriers, and cross-sectional surveys cannot determine whether recognition patterns have changed over time.